ALLIGATOR BIOSCIENCE AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.929 SEK | +0.98% |
|
-10.67% | +34.83% |
Chart calendar Alligator Bioscience AB
083cd5de55fe14745552dcb8a8.Oavt_Mof4FwikSHhuLBBu-mIeU14diBz-1l_jQrqUXY.cNuVhb9UpDgR1xjT9sgswr_nEiI3Txg41hUOxE26NAFI-4CU8mWuZG3JGQ~2ce45713cdc19cc3a62ba20812d54934
Upcoming events on Alligator Bioscience AB
Past events on Alligator Bioscience AB
| 2024-03-14 06:30 am | Extraordinary Shareholders Meeting |
| 2024-02-09 08:00 am | Q4 2023 Earnings Call |
| 2024-02-08 02:00 am | Q4 2023 Earnings Release |
| 2024-01-29 10:00 am | Mitazalimab OPTIMIZE-1 Phase 2 Study Results Call |
| 2024-01-24 03:15 am | Redeye Theme: Fight Cancer |
| 2023-12-01 08:00 am | Capital Markets Day |
| 2023-10-26 06:30 am | Q3 2023 Earnings Call |
| 2023-10-26 02:00 am | Q3 2023 Earnings Release |
| 2023-07-13 10:00 am | Q2 2023 Earnings Call |
| 2023-07-13 02:00 am | Q2 2023 Earnings Release |
| 2023-05-09 | Redeye Medtech Forum |
| 2023-05-02 | Annual General Meeting |
| 2023-04-25 | Redeye Orphan Drugs Event |
| 2023-04-25 06:30 am | Q1 2023 Earnings Call |
| 2023-04-25 02:00 am | Q1 2023 Earnings Release |
| 2023-04-24 05:00 am | Extraordinary Shareholders Meeting |
| 2023-04-17 01:30 pm | American Association for Cancer Research Meeting - Abstract Number: 2939 |
| 2023-03-13 | Investor Meeting |
| 2023-02-10 08:00 am | Q4 2022 Earnings Call |
| 2023-02-10 02:00 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 5,40 2,04 164.94% | 6,67 5,90 12.98% | 15,1 10,6 42.16% | 37,1 25,9 43.36% | 61,9 97,1 -36.26% | 266 |
|
EBITDA Million SEK | Released Forecast Spread | -203 -205 0.82% | -133 -130 -2.29% | -130 -132 1.18% | -181 -176 -3.01% | -238 -160 -48.62% | 6,93 |
|
EBIT Million SEK | Released Forecast Spread | -215 -211 -1.66% | -144 -142 -1.56% | -142 -143 1.28% | -193 -185 -4.34% | -249 -171 -45.41% | -1,32 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -210 -210 -0.06% | -143 -141 -1.59% | -142 -143 1.06% | -193 -184 -4.91% | -249 -146 -70.47% | -0,98 |
|
Net income Million SEK | Released Forecast Spread | -210 -210 -0.06% | -143 -141 -1.59% | -142 -143 1.08% | -193 -184 -4.91% | -249 -171 -45.76% | -0,98 |
|
EPS SEK | Released Forecast Spread | -2,94 -2,94 0.03% | -2,01 -1,98 -1.75% | -0,64 -1,63 60.82% | -0,88 -0,81 -8.96% | -0,55 -0,29 -88.81% | -0,53 |
| Announcement Date | 12/02/20 | 26/02/21 | 11/02/22 | 10/02/23 | 08/02/24 | - |
More events
Past sector events for Alligator Bioscience AB
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ATORX Stock
- Calendar Alligator Bioscience AB
